Heparin-binding epidermal growth factor-like growth factor decreases the incidence of necrotizing enterocolitis in neonatal rats

Journal of Pediatric Surgery

Volumn 41, Issue 1, 2006, Pages 144-149

  Feng, Jiexiong ^a   El Assal, Osama N ^a   Besner, Gail E ^a,b  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

HB EGF; Mucosal permeability; Necrotizing enterocolitis

Indexed keywords

FLUORESCEIN ISOTHIOCYANATE DEXTRAN; HEPARIN BINDING EPIDERMAL GROWTH FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ARTIFICIAL MILK; BREAST FEEDING; CONTROLLED STUDY; DISEASE SEVERITY; HYPOTHERMIA; HYPOXIA; INCIDENCE; INTESTINE MUCOSA PERMEABILITY; NECROTIZING ENTEROCOLITIS; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; SURVIVAL RATE;

ADMINISTRATION, ORAL; ANIMALS; ANIMALS, NEWBORN; DISEASE MODELS, ANIMAL; ENTEROCOLITIS, NECROTIZING; EPIDERMAL GROWTH FACTOR; INTESTINAL MUCOSA; PERMEABILITY; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; SEVERITY OF ILLNESS INDEX;

EID: 30344481970     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpedsurg.2005.10.018     Document Type: Article

References (19)

1. R.M. Kliegman, and A.A. Fanaroff Necrotizing enterocolitis N Engl J Med 310 1984 1093 1103
2. J. Feng, O.N. El-Assal, and G.E. Besner Heparin-binding EGF-like growth factor (HB-EGF) and necrotizing enterocolitis Semin Pediatr Surg 14 2005 167 174
3. G.E. Besner, S. Higashiyama, and M. Klagsbrun Isolation and characterization of a macrophage-derived heparin-binding growth factor Cell Regul 1 1990 811 819
4. O.N. El-Assal, and G.E. Besner Heparin-binding EGF-like growth factor (HB-EGF) and intestinal ischemia-reperfusion injury Semin Pediatr Surg 13 2004 2 10
5. B. Barlow, T.V. Santulli, and W.C. Heird An experimental study of acute neonatal enterocolitis-the important of breast milk J Pediatr Surg 9 1974 587 595
6. M.S. Caplan, E. Hedlund, and L. Adler Role of asphyxia and feeding in a neonatal rat model of necrotizing enterocolitis Pediatr Pathol 14 1994 1017 1028
7. M.S. Caplan, R. Miller-Catchpole, and S. Kaup Bifidobacterial supplementation reduces the incidence of necrotizing enterocolitis in a neonatal rat model Gastroenterology 117 1999 577 583
8. E.A. Deitch Role of bacterial translocation in necrotizing enterocolitis Acta Paediatr Suppl 396 1994 33 36
9. M. Piena, M.J. Albers, and P.M. Van Haard Introduction of enteral feeding in neonates on extracorporeal membrane oxygenation after evaluation of intestinal permeability changes J Pediatr Surg 33 1998 30 34
10. S. Mishima, D. Xu, and E.A. Deitch Increase in endotoxin-induced mucosal permeability is related to increase nitric oxide synthase activity using the Ussing chamber Crit Care Med 27 1999 880 886
11. Y. Ohashi, Y. Nakai, and K. Morimoto Platelet activating factor compromises airway epithelial defense function J Allergy Clin Immunol 100 1997 520 526
12. A.P. Sober, C.W. Marano, and M. Bryans Activation of NF-kappa B is necessary for the restoration of the barrier function of an epithelium undergoing TNF-α-induced apoptosis Eur J Cell Biol 78 1999 56 66
13. D.Z. Xu, Q. Lu, and R. Kubicka The effect of hypoxia/reoxygenation on the cellular function of an epithelial cells J Trauma 46 1999 280 285
14. H. Schmitz, M. Fromm, and C.J. Bentzel Tumor necrosis factor-α (TNF-α) regulates the epithelial barrier in the human intestinal cell line HT-29/B6 J Cell Sci 112 1999 137 146
15. W. Hsueh, M.S. Caplan, and X. Sun Platelet-activating factor, tumor necrosis factor, hypoxia and necrotizing enterocolitis Acta Paediatr Suppl 396 1994 11 17
16. W. Hsueh, M.S. Caplan, and X. Qu Neonatal necrotizing enterocolitis: clinical considerations and pathogenetic concepts Pediatr Dev Pathol 6 2002 6 23
17. G. Xia, A.E. Martin, and M.P. Michalsky Heparin-binding EGF-like growth factor preserves crypt cell proliferation and decreases bacterial translocation after intestinal ischemia/reperfusion injury J Pediatr Surg 37 2002 1081 1087
18. G. Xia, A.W. Rachfal, and A.E. Martin Upregulation of endogenous heparin-binding EGF-like growth factor (HB-EGF) expression after intestinal ischemia reperfusion injury J Invest Surg 16 2003 57 63
19. Martin A, Besner G. Timing, route and dose of administration of heparin-binding EGF-like growth factor (HB-EGF) in protection against intestinal ischemia-reperfusion injury. J Pediatr Surg (in press).